CHEMSAVE
LIVE

Serial Number

79332803

Owner

SEEPEX GMBH

Attorney

Carlynn Ferguson

Filing Date

Jun 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CHEMSAVE Trademark

Serial Number: 79332803 • Registration: 6988112

CHEMSAVE is a trademark filed by SEEPEX GMBH on June 4, 2021. The trademark is classified under Class 7 (Machinery), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

SEEPEX GMBH (7 trademarks)

BOTTROP D46240 , DE

Entity Type: 03

Trademark Details

Filing Date

June 4, 2021

Registration Date

February 28, 2023

Published for Opposition

December 13, 2022

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 28, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 2, 2023 FICS
FINAL DISPOSITION PROCESSED
Jun 2, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Dec 13, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 22, 2022 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 15, 2022 MAFR
ASSIGNED TO EXAMINER
Feb 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 10, 2022 REPR